The observation found that tumor macrophage infiltrates enhanced T-cell-mediated control of tumor growth after the anti-TREM2 therapy; the anti-TREM2 mAb to tumor-bearing mice blunted tumor growth and strongly enhanced the efficacy of anti-PD-1 immunotherapy (181). This evidence concerns the gene TREM2 and neoplasm.